Connect with us

National

Stage is set for phase II trials of Bharat Biotech’s COVID vaccine

The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday.

The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin.

Joint Drugs Controller Dr S. Eswara Reddy wrote a letter to Bharat Biotech International, conveying the organisation’s nod for conducting the phase II trials.

These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for four days after they receive the vaccine shots.

Joint Drugs Controller said that the directorate had no objection to conducting the trial titled ‘An adaptive, seamless Phase I, followed by Phase II randomized, double-blind, multicentre study to evaluate the safety, reactogenicity, tolerability and immunogenicity of the whole-virion inactivated SARS-CoV-2 vaccine (BBV152) in healthy volunteers’.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published.

Local

Advertisement

Facebook

Visitors

137274
Total Users : 74964
Views Today : 7121
Total views : 559268

Copyright © 2020 JK Media. Powered by Rodiex